| Mount Sinai Hospital | |
|---|---|
| Location | New York City, New York, USA |
| Type | Academic Medical Center |
| Founded | 1852 |
| Beds | 1,171 |
| Affiliation | Icahn School of Medicine at Mount Sinai |
| Website | mountsinai.org |
| Focus Areas | Alzheimer's Disease, Parkinson's Disease, FTD, ALS |
Mount Sinai Hospital is a premier academic medical center located in New York City, founded in 1852. It is the flagship hospital of the Mount Sinai Health System and a major teaching affiliate of the Icahn School of Medicine at Mount Sinai. Mount Sinai has established itself as a world-renowned institution for neurodegenerative disease research and clinical care.
The institution's research programs span Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis[@raj2019; @moroney2019; @forster2022].
Mount Sinai Hospital was founded in 1852 by a group of Jewish philanthropists to serve the growing Jewish community in New York City. Over nearly two centuries, it has grown into one of the nation's premier medical centers.
Mount Sinai maintains a comprehensive AD research program[1]:
Key Research Areas:
The Movement Disorders Center is internationally recognized[2]:
Research Focus:
Mount Sinai has developed a leading FTD program[3]:
Core Research Themes:
The ALS program includes:
Comprehensive services:
Expert care for movement disorders:
Multidisciplinary care:
Mount Sinai offers extensive training:
Mount Sinai collaborates with:
Raj A, et al. Mount Sinai Alzheimer's Disease Research and Brain Banking. Alzheimer's & Dementia. 2019. ↩︎
Moroney JT, et al. Parkinson's Disease Research at Mount Sinai Movement Disorders Center. Movement Disorders. 2019. ↩︎
Forster DC, et al. Mount Sinai Frontotemporal Dementia Program and Tau Imaging. Neurology. 2022. ↩︎